Literature DB >> 17392032

Psychological profile of adults with tuberous sclerosis complex.

Margaret B Pulsifer1, Elisabeth B Winterkorn, Elizabeth A Thiele.   

Abstract

The Symptom Checklist-90-Revised, a standardized self-report measure of psychological symptoms, was administered to 42 adults with tuberous sclerosis complex (TSC). Approximately 45% reported high overall psychological distress, most commonly involving interpersonal sensitivity, psychoticism, depression, and obsessive-compulsive symptoms. Symptoms were related to number of organ systems affected by TSC and, in some cases, to seizure history, but not to genotype, IQ, education, severity of epilepsy, or use of anticonvulsant or psychiatric medication.

Entities:  

Mesh:

Year:  2007        PMID: 17392032     DOI: 10.1016/j.yebeh.2007.02.004

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  18 in total

Review 1.  A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).

Authors:  Petrus J de Vries; Lucy Wilde; Magdalena C de Vries; Romina Moavero; Deborah A Pearson; Paolo Curatolo
Journal:  Am J Med Genet C Semin Med Genet       Date:  2018-08-16       Impact factor: 3.908

2.  NitroSynapsin for the treatment of neurological manifestations of tuberous sclerosis complex in a rodent model.

Authors:  Shu-Ichi Okamoto; Olga Prikhodko; Juan Pina-Crespo; Anthony Adame; Scott R McKercher; Laurence M Brill; Nobuki Nakanishi; Chang-Ki Oh; Tomohiro Nakamura; Eliezer Masliah; Stuart A Lipton
Journal:  Neurobiol Dis       Date:  2019-03-27       Impact factor: 5.996

Review 3.  Mechanism-based treatment in tuberous sclerosis complex.

Authors:  Kristina Jülich; Mustafa Sahin
Journal:  Pediatr Neurol       Date:  2013-12-05       Impact factor: 3.372

4.  Characterizing sleep disorders of adults with tuberous sclerosis complex: a questionnaire-based study and review.

Authors:  Agnies M van Eeghen; Adam I Numis; Brigid A Staley; Samuel E Therrien; Ronald L Thibert; Elizabeth A Thiele
Journal:  Epilepsy Behav       Date:  2010-12-03       Impact factor: 2.937

5.  Increased levels of anxiety-related behaviors in a Tsc2 dominant negative transgenic mouse model of tuberous sclerosis.

Authors:  Dan Ehninger; Alcino J Silva
Journal:  Behav Genet       Date:  2010-09-30       Impact factor: 2.805

Review 6.  Tuberous sclerosis complex: neurological, renal and pulmonary manifestations.

Authors:  D N Franz; J J Bissler; F X McCormack
Journal:  Neuropediatrics       Date:  2011-01-05       Impact factor: 1.947

7.  Recognition of tuberous sclerosis in adult women: delayed presentation with life-threatening consequences.

Authors:  Diane Seibert; Chien-Hui Hong; Fumiko Takeuchi; Cara Olsen; Olonda Hathaway; Joel Moss; Thomas N Darling
Journal:  Ann Intern Med       Date:  2011-06-21       Impact factor: 25.391

Review 8.  From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis.

Authors:  D Ehninger; P J de Vries; A J Silva
Journal:  J Intellect Disabil Res       Date:  2009-08-19

9.  Understanding relationships between autism, intelligence, and epilepsy: a cross-disorder approach.

Authors:  Agnies M van Eeghen; Margaret B Pulsifer; Vanessa L Merker; Ann M Neumeyer; Elmer E van Eeghen; Ronald L Thibert; Andrew J Cole; Fawn A Leigh; Scott R Plotkin; Elizabeth A Thiele
Journal:  Dev Med Child Neurol       Date:  2012-12-04       Impact factor: 5.449

Review 10.  The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth.

Authors:  Sam Amin; Andrew Lux; Finbar O'Callaghan
Journal:  Br J Clin Pharmacol       Date:  2018-11-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.